Join Dr. Karen Herbst and Dr. Nicholas Pennings for the October edition of the Research Roundtable. This enlightening discussion explores the complexities of obesity—its definition beyond BMI, its relationship to conditions like lipedema and lymphedema, and the importance of personalized, comprehensive care.
Dr. Pennings, Executive Director of Clinical Education and Master Fellow of the Obesity Medicine Association, shares cutting-edge insights on the role of GLP-1 receptor agonists and new medications such as tirzepatide in reducing appetite, inflammation, and improving metabolic health. “Shutting down the food noise is just the tip of the iceberg,” he shares.
Together, Dr. Herbst and Dr. Pennings discuss how combining lifestyle strategies with these emerging therapies can lead to sustained weight loss and better overall well-being. They also look ahead to the future of obesity treatment and answer audience questions on fat distribution, inflammation in lipedema, and the impact of fatty liver disease—leaving viewers with a message of hope and practical guidance for restoring metabolic health.
This Roundtable was originally recorded live on October 6, 2025. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or positions of Lympha Press. The content is for educational purposes only and not intended as medical advice.
Watch more Roundtables from our Lympha Press Research Roundtables playlist on YouTube.
